Introduction
The ongoing program for eradication of polio has resulted in a sharp decline in the incidence of paralytic poliomyelitis in our country. This has led to the emergence of Guillain Barré Syndrome (GBS) as the most common cause of acute flaccid paralysis.
1 GBS is usually a rapidly progressive, predominantly motor neuropathy, which often results in bulbar and respiratory compromise. Residual motor-sensory deficits can persist, and death, when occurs, is usually early in the disease course, and as a result of respiratory compromise or autonomic failure or intensive care unit complications. While the exact etiology of GBS still remains elusive, many investigators have thus far concluded that it has an autoimmune pathophysiology. These events are most likely triggered by common infections. Environmental and seasonal factors also play a role through incompletely understood mechanisms. Both components of immunity-humoral as well as cellular-are involved, leading to inflammatory cell infiltration and demyelination of the peripheral nerves. This is not the only pathology, as the current definition of GBS encompasses other variants such as acute motor axonal neuropathy (AMAN), acute motor-sensory axonal neuropathy (AMSAN), and Miller Fisher Syndrome (MFS) etc. 2, 3, 4, 5 Guillain Barré Syndrome affects all age groups, from infancy to old age, with age-specific features. In general, functional recovery is reported to be better in the pediatric age group. GBS is a global disease. Though reportable in the national acute flaccid paralysis surveillance program, there have been only few systematic studies of this syndrome, especially so in the north India, with very few reports available. The purpose of our study is to review the key presenting features and outcome of patients of Guillain Barré Syndrome (GBS) presenting as outpatients and inpatients to the Kalawati Saran Children's Hospital, New Delhi, India, over a period of five years. This study was based on the data collected over a period from Jan 2001 to Sept 2005 at Kalawati Saran Children hospital, New Delhi. Being a nodal center for AFP cases, a large number of GBS cases were managed in the said hospital. It was found that GBS occurs at all the ages in children (up to 18 years of age), however, the peak incidence in our study was between 2-4 years of age. There were 40/184 (21.73%) cases below 3 years of age. The youngest reported case in our study was a 13-month-old male child. Similar were the finding in a comparative study done at Aga Khan University College in Karachi, Pakistan. 8 In one study on GBS from Brazil, the authors reported 2 peaks one at 2-4 years of age and another in the adult population. In accordance with most of the western and Asian studies, GBS was more common in males in our study, with 71.74% being males and male female ratio was 2.54:1. No precise cause for that was found.
Materials and Methods
There was a definite pattern of seasonal variation with maximum number of children presenting during the summer and early rainy season. We observed two peaks, one in the summer and early rainy season and the second in winter. (Fig 1) It can be attributed to the sudden increase in waterborne diseases during summer season. The second peak coincides with the increased number of acute respiratory infection (ARI) in the winter season. Similar were the findings of a study from northern China where seasonal predominance was evident in the summer months and was correlated with infection with Campylobacter jejuni and poor personal hygiene. 10, 11 In contrast, a Taiwanese study reported a seasonal predominance in the winter time due to increase in ARI in those months and ARI being the most frequent antecedent infection in their patients. 10 In the present study children with diarrhea as an antecedent event were associated with more severe disease in 76.47% of patients. In comparison to GBS in the adults, childhood GBS takes shorter time to reach the peak weakness and also has a shorter recovery period. In our study we found that the mean duration to reach peak weakness was 4.75±2.92 days whereas 
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Hung el al reported it as 9.7±7.0 and 10.7±11.1 days for children and adults respectively. 10 The most common clinical manifestation in our children was muscle weakness (100%) followed by pain/paresthesia in 31.52% of them, which was consistent with other studies. Cranial nerve involvement was found in less number of patients (bulbar palsy in 13.11% and 7 th nerve palsy in 1.07%) in comparison to other studies where the cranial nerves were involved in more than 30-42% of the cases. 10 No case of Miller-Fisher variant was found. Nineteen patients (10.32%) were put on mechanical ventilation during the hospital stay, of which 5 patients died due to respiratory complications and associated severe autonomic dysfunction. Patients with respiratory failure associated with bulbar palsy and autonomic dysfunction had poorer outcome as compared to the patients with respiratory failure alone.
Regarding the NCV, our findings of demyelinating polyneuropathy, as the most common presentation is consistent with most of the studies done on both children and adults. But quite a large number of children (34.04%) remained unclassified (non excitable nerve) in our series. The possible explanation for this could be that the NCV study was done in the 2 nd week of the onset of illness whereas the mean duration of peak illness was 4.75+-2.92 days in our study, and as the disease progress rapidly in children as compared to adults and with diffuse changes after complete progression, nerves become not excitable and we could not classify these cases. Also, no standardization of electrophysiological criteria for children <5 years of age are available. 12, 13 causes related to GBS and there was no follow-up data for 22 patients. 6 patients who were in stage V at the time of presentation, 3 died during the acute stage of illness, 2 recovered and were walking independently with minimal deficit within 6 months while the remaining one patient was lost to follow-up.
As there was no long-term sequealae found in our patients, this reaffirms that if pediatric patients are managed optimally in the acute stage, complete recovery can be ensured.
